Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab
- Sponsor
- Federico II University
- Study ID
- NCT04310631
- Status
- Completed
Conditions
- Coats Disease
Eligibility Criteria
- Sex
- MALE
- Age
- 19 Years - 30 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ranibizumab Injection — DRUGRanibizumab Injection (0.5 mg/0.05 ml): Three monthly intravitreal injections
Study Details
This study evaluates the retinal and vascular features in patients affected by Coats disease under the effects of Ranibizumab intravitreal injections using optical coherence tomography and optical coherence tomography angiography
Key Dates
- First listed
- Mar 17, 2020
- Start date
- Jan 1, 2016
- Status verified
- Mar 2020
- Primary completion
- Dec 31, 2019
- Completion
- Dec 31, 2019
Study Design
- Enrollment
- 5 participants (actual)
Primary Outcome Measure
Study of retinal and vascular features in Coats disease after intravitreal injections of Ranibizumab [ Time Frame: Three months ]